| Original language | English |
|---|---|
| Pages (from-to) | 994-995 |
| Number of pages | 2 |
| Journal | JACC: Cardiovascular Imaging |
| Volume | 16 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2023 |
| Externally published | Yes |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: JACC: Cardiovascular Imaging, Vol. 16, No. 7, 07.2023, p. 994-995.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Reply
T2 - Is Bolus-Thermodilution Reliable in Defining Coronary Microvascular Dysfunction?
AU - Gould, K. Lance
AU - Johnson, Nils P.
AU - Narula, Jagat
N1 - Funding Information: This research is supported by internal funds from the Weatherhead PET Imaging Center. Dr Johnson has received internal funding from the Weatherhead PET Imaging Center; and has received research support from St. Jude Medical ( NCT02184117 ) and Volcano/Philips Corporation ( NCT02328820 ). Dr Gould has received internal funding from the Weatherhead PET Imaging Center; and is the applicant for 510(k) U.S. Food and Drug Administration–cleared HeartSee K171303 positron emission tomographic software. To avoid any conflict of interest, Drs Gould and Johnson waived their rights to the royalties they were personally eligible to receive from sales of the intellectual property developed by them and licensed by UTHealth to third parties. UTHealth approved their request that all derived royalties be redirected to student scholarships or UTHealth’s Weatherhead PET Imaging Center research. UTHealth has a financial interest related to intellectual property through its affiliation with UTHealth’s Weatherhead PET Imaging Centers. Dr Narula has reported that he has no relationships relevant to the contents of this paper to disclose. Funding Information: This research is supported by internal funds from the Weatherhead PET Imaging Center. Dr Johnson has received internal funding from the Weatherhead PET Imaging Center; and has received research support from St. Jude Medical (NCT02184117) and Volcano/Philips Corporation (NCT02328820). Dr Gould has received internal funding from the Weatherhead PET Imaging Center; and is the applicant for 510(k) U.S. Food and Drug Administration–cleared HeartSee K171303 positron emission tomographic software. To avoid any conflict of interest, Drs Gould and Johnson waived their rights to the royalties they were personally eligible to receive from sales of the intellectual property developed by them and licensed by UTHealth to third parties. UTHealth approved their request that all derived royalties be redirected to student scholarships or UTHealth's Weatherhead PET Imaging Center research. UTHealth has a financial interest related to intellectual property through its affiliation with UTHealth's Weatherhead PET Imaging Centers. Dr Narula has reported that he has no relationships relevant to the contents of this paper to disclose.
PY - 2023/7
Y1 - 2023/7
UR - https://www.scopus.com/pages/publications/85162985509
U2 - 10.1016/j.jcmg.2023.04.010
DO - 10.1016/j.jcmg.2023.04.010
M3 - Letter
AN - SCOPUS:85162985509
SN - 1936-878X
VL - 16
SP - 994
EP - 995
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 7
ER -